Status:
COMPLETED
Evaluation of Quality of Care - Shared-Care Programme, HA
Lead Sponsor:
The University of Hong Kong
Collaborating Sponsors:
Hospital Authority, Hong Kong
Conditions:
Diabetes Mellitus
Eligibility:
All Genders
18+ years
Brief Summary
Diabetes mellitus (DM) and hypertension (HT) are major causes of morbidity and among the top 10 causes of deaths in Hong Kong in 2008 (Department of Health 2009). The Hospital Authority (HA) has initi...
Eligibility Criteria
Inclusion
- Patients with diabetes mellitus who have received care at the specialist outpatient clinic (SOPC)for at least 2 years, stratified to be of low risk and have normal renal function as defined by the plasma creatinine level.
Exclusion
- Patients will be excluded if they are stratified to be at high cardiovascular risk or are suffering end stage renal failure, on dialysis or after transplantation, or on insulin, or do not give consent to be transferred.
Key Trial Info
Start Date :
September 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2015
Estimated Enrollment :
620 Patients enrolled
Trial Details
Trial ID
NCT03334370
Start Date
September 1 2010
End Date
September 1 2015
Last Update
November 7 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The University of Hong Kong
Hong Kong, Hksar, Hong Kong